NewKerala.com

India-Swiss Pharma Partnership: How New Deals Could Transform Healthcare

India and Switzerland are exploring deeper collaboration in pharmaceuticals and biotechnology. Commerce Minister Piyush Goyal met with Swiss State Secretary Helene Budliger Artieda to discuss expanding investment opportunities. Both sides reviewed progress under the India-EFTA Trade and Economic Partnership Agreement. The talks focused on strengthening healthcare delivery and manufacturing capacities through innovation-driven investments.

Key Points: Piyush Goyal Meets Swiss Official for Pharma Investment Talks

  • Piyush Goyal meets Swiss State Secretary Helene Budliger Artieda for bilateral talks
  • Focus on expanding Swiss pharma investments in India's healthcare sector
  • Progress reviewed under India-EFTA Trade and Economic Partnership Agreement
  • Discussions covered research cooperation and innovation-driven investments
2 min read

India, Switzerland discuss pharma & biotech collaboration as Piyush Goyal meets Swiss State Secretary for Economic Affairs

India and Switzerland discuss pharma and biotech collaboration as Piyush Goyal meets Swiss State Secretary Helene Budliger Artieda to expand investment opportunities.

"Discussions focused on avenues of further cooperation in R&D and expanding investment opportunities for Swiss pharma companies to leverage India's robust healthcare sector. - Piyush Goyal"

New Delhi, November 27

Union Commerce and Industry Minister Piyush Goyal met visiting Swiss State Secretary for Economic Affairs, Helene Budliger Artieda, and discussed cooperation in research and development and to expand investment opportunities for Swiss pharmaceutical companies in India's growing healthcare sector.

Artieda is on a visit to India along with a delegation of Swiss pharma and biotech firms.

Goyal said on X, "Co-chaired a meeting with @SECO_StateSec Ms. Helene Budliger Artieda with Swiss pharma and biotech companies. Discussions focused on avenues of further cooperation in R&D and expanding investment opportunities for Swiss pharma companies to leverage India's robust healthcare sector."

He also added that both sides "discussed the progress made under the India-EFTA Trade & Economic Partnership Agreement (TEPA) with an aim to further enhance collaboration across key sectors for mutual growth."

With the India-EFTA TEPA talks progressing, both countries are seeking ways to boost trade and encourage innovation-driven investments that can strengthen healthcare delivery and manufacturing capacities.

To boost Pharma exports, earlier this week, Goyal held an interaction with key stakeholders from India's pharmaceutical ecosystem, focusing on strengthening industry growth and regulatory reforms.

In a social media post on Monday, the minister stated that he had an engaging discussion with industry representatives aimed at enhancing India's position in the global pharma landscape.

He said, "Had an engaging interaction with key stakeholders from India's pharma ecosystem, focusing on strengthening our regulatory frameworks and accelerating growth. Discussed industry perspectives on innovation, data protection frameworks, investment commitments and opportunities to scale manufacturing in India."

The meeting highlighted India's focus on building stronger partnerships with global players in the pharmaceutical and biotechnology sectors.

Goyal further reiterated the Modi Government's commitment to developing a future-ready, innovation-led pharma sector capable of boosting competitiveness and attracting high-quality investments. He added that the government remains focused on delivering affordable, world-class healthcare solutions.

- ANI

Share this article:

Reader Comments

R
Rohit P
Finally some positive developments in pharma sector. India has the potential to become the pharmacy of the world, but we need foreign partnerships for advanced R&D. Good move by the government! 👍
A
Arjun K
While collaborations are good, I hope our government ensures that Indian companies get fair technology transfer and don't become just manufacturing hubs for foreign giants. We need to protect our domestic industry interests too.
S
Sarah B
As someone working in healthcare, this partnership could be transformative. Swiss expertise in biotechnology combined with India's manufacturing capabilities can create world-class healthcare solutions. Exciting times ahead!
M
Michael C
Hope this leads to more job opportunities for Indian scientists and researchers. We have brilliant minds in biotechnology who deserve global exposure and better career prospects.
N
Nikhil C
The focus on regulatory reforms is much needed. Our pharma sector needs streamlined processes and better IP protection to attract quality investments. Good to see the government addressing these issues systematically.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50